Mettler-Toledo International (NYSE:MTD) PT Raised to $1,400.00 at JPMorgan Chase & Co.

Mettler-Toledo International (NYSE:MTD) had its price objective increased by JPMorgan Chase & Co. from $1,300.00 to $1,400.00 in a research report report published on Monday morning, Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the medical instruments supplier’s stock.

MTD has been the subject of several other research reports. Jefferies Financial Group reaffirmed an underperform rating and set a $1,250.00 price target (up previously from $1,230.00) on shares of Mettler-Toledo International in a research report on Monday, June 3rd. StockNews.com upgraded shares of Mettler-Toledo International from a hold rating to a buy rating in a research report on Thursday, July 11th. Stifel Nicolaus raised their target price on shares of Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the company a buy rating in a report on Monday. The Goldman Sachs Group lifted their price target on Mettler-Toledo International from $1,150.00 to $1,300.00 and gave the stock a neutral rating in a research report on Tuesday, July 9th. Finally, Robert W. Baird upped their price objective on Mettler-Toledo International from $1,212.00 to $1,360.00 and gave the company a neutral rating in a research report on Monday, May 13th. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of Hold and an average target price of $1,343.75.

Mettler-Toledo International Price Performance

Mettler-Toledo International stock opened at $1,395.33 on Monday. The business’s fifty day moving average is $1,409.12 and its 200 day moving average is $1,332.22. Mettler-Toledo International has a one year low of $928.49 and a one year high of $1,546.93. The stock has a market capitalization of $29.80 billion, a PE ratio of 39.13, a price-to-earnings-growth ratio of 4.06 and a beta of 1.17.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, August 1st. The medical instruments supplier reported $9.65 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.00 by $0.65. The company had revenue of $946.75 million for the quarter, compared to analysts’ expectations of $929.13 million. Mettler-Toledo International had a net margin of 20.95% and a negative return on equity of 590.80%. The firm’s quarterly revenue was down 3.6% on a year-over-year basis. During the same quarter last year, the company posted $10.19 earnings per share. As a group, sell-side analysts expect that Mettler-Toledo International will post 40.13 EPS for the current fiscal year.

Insider Activity

In related news, CFO Shawn Vadala sold 300 shares of the firm’s stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $1,528.43, for a total transaction of $458,529.00. Following the completion of the sale, the chief financial officer now directly owns 4,914 shares of the company’s stock, valued at approximately $7,510,705.02. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $1,528.43, for a total transaction of $458,529.00. Following the completion of the sale, the chief financial officer now owns 4,914 shares in the company, valued at approximately $7,510,705.02. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Gerry Keller sold 310 shares of the firm’s stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $1,511.56, for a total transaction of $468,583.60. Following the transaction, the insider now directly owns 6 shares in the company, valued at $9,069.36. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 3,278 shares of company stock valued at $4,871,849. 1.94% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Mettler-Toledo International

Several hedge funds have recently made changes to their positions in MTD. Raymond James Financial Services Advisors Inc. raised its holdings in shares of Mettler-Toledo International by 25.4% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 1,676 shares of the medical instruments supplier’s stock valued at $2,033,000 after acquiring an additional 340 shares in the last quarter. DAVENPORT & Co LLC bought a new stake in shares of Mettler-Toledo International in the 4th quarter valued at about $997,000. Trust Point Inc. purchased a new stake in Mettler-Toledo International during the fourth quarter worth $224,000. Allworth Financial LP boosted its position in Mettler-Toledo International by 100.0% during the 4th quarter. Allworth Financial LP now owns 32 shares of the medical instruments supplier’s stock valued at $39,000 after acquiring an additional 16 shares in the last quarter. Finally, International Assets Investment Management LLC increased its holdings in shares of Mettler-Toledo International by 109,458.1% in the 4th quarter. International Assets Investment Management LLC now owns 67,926 shares of the medical instruments supplier’s stock valued at $82,392,000 after acquiring an additional 67,864 shares during the period. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems.